Dr Lal Pathlabs' Q4 FY 2025-26 Quarterly Results

Result Summary

• Dr Lal Pathlabs Ltd reported a 6.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 15.6%.
• Its expenses for the quarter were up by 6.9% QoQ and 19.3% YoY.
• The net profit increased 44.6% QoQ and decreased 15.0% YoY.
• The earnings per share (EPS) of Dr Lal Pathlabs Ltd stood at 7.85 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Dr Lal Pathlabs Ltd is a leading diagnostic and healthcare service provider in India. The company specializes in offering a wide range of laboratory testing and diagnostic services. As one of the largest players in the organized diagnostic sector in India, Dr Lal Pathlabs operates through a network of laboratories and patient service centers. The primary services include pathology and radiology tests, catering to both individual patients and corporate clients. Recent major developments for the company are not available in the provided data, but historically, Dr Lal Pathlabs has focused on expanding its reach and enhancing its service offerings to maintain a competitive edge in the healthcare diagnostics industry.

Revenue

In Q4FY26, Dr Lal Pathlabs Ltd reported a total income of ₹726.70 crores, an increase from ₹684.20 crores in the previous quarter (Q3FY26) and ₹628.40 crores in the same quarter of the previous year (Q4FY25). This reflects a quarter-over-quarter (QoQ) growth rate of 6.2% and a year-over-year (YoY) growth rate of 15.6%. The company's consistent growth in revenue can be attributed to its expansive service network and the increasing demand for healthcare diagnostics. The revenue figures indicate the company's ability to maintain an upward trajectory in income generation across its operations.

Profitability

Dr Lal Pathlabs Ltd's profitability metrics for Q4FY26 show a Profit Before Tax (PBT) of ₹160.10 crores, up from ₹124.30 crores in Q3FY26 and ₹153.40 crores in Q4FY25. The QoQ increase in PBT is 28.8%, while the YoY increase is 4.4%. The Tax expense for Q4FY26 is ₹27.90 crores, compared to ₹32.90 crores in Q3FY26 and a negative tax of ₹-2.10 crores in Q4FY25. The Profit After Tax (PAT) for Q4FY26 stands at ₹132.20 crores, rising from ₹91.40 crores in Q3FY26 but showing a decrease from ₹155.50 crores in Q4FY25, reflecting a QoQ growth of 44.6% and a YoY decline of 15.0%. Earnings Per Share (EPS) for Q4FY26 is ₹7.85, compared to ₹5.41 in Q3FY26 and ₹18.54 in Q4FY25, indicating a QoQ growth of 45.1% and a YoY decline of 57.7%.

Operating Metrics

The financial data for Dr Lal Pathlabs Ltd in Q4FY26 shows total expenses of ₹566.60 crores, which have increased from ₹529.80 crores in Q3FY26 and ₹475.00 crores in Q4FY25. This translates to a QoQ increase of 6.9% and a YoY increase of 19.3%. The rise in expenses can be correlated with the company's operational activities necessary to support its growth in revenue. The significant changes in tax expenses, particularly the YoY shift from a negative tax figure in Q4FY25 to a positive tax in Q4FY26, may reflect adjustments in the company's tax liabilities or benefits. Overall, the operating metrics highlight the company's financial management in maintaining operational efficiency while expanding its income base.